Related Experiment Video
Updated: Jun 17, 2026
06:10
Encapsulated Cell Technology for the Delivery of Biologics to the Mouse Eye
Published on: March 30, 2020
Anti-VEGF therapy for glaucoma
Michael B Horsley1, Malik Y Kahook
1Department of Ophthalmology, Rocky Mountain Lions Eye Institute, University of Colorado School of Medicine, Aurora, Colorado 80045, USA.
Current Opinion in Ophthalmology
|December 31, 2009
Summary
Antivascular endothelial growth factor (anti-VEGF) agents show promise for treating neovascular glaucoma and improving wound healing after glaucoma surgery. Further research is needed to confirm these benefits in clinical trials.
Area of Science:
- Ophthalmology
- Vascular Biology
- Glaucoma Research
Background:
- Antivascular endothelial growth factor (anti-VEGF) agents are under investigation for ophthalmic applications.
- Understanding of anti-VEGF mechanisms and clinical application in neovascular glaucoma is evolving.
- Emerging research explores anti-VEGF agents for modulating wound healing after trabeculectomy.
Purpose of the Study:
- To review the current role and potential applications of anti-VEGF agents in ophthalmology.
- To evaluate the efficacy of anti-VEGF agents in treating neovascular glaucoma.
- To assess the utility of anti-VEGF agents in wound modulation following glaucoma surgery.
Main Methods:
- Review of recent studies on anti-VEGF agents in ophthalmology.
- Analysis of clinical outcomes in patients with neovascular glaucoma treated with anti-VEGF agents.
- Examination of research on the effects of anti-VEGF agents on fibroblast proliferation and wound healing.
Main Results:
- Anti-VEGF agents effectively reduce neovascularization in the iris and anterior chamber angle.
- Treatment with anti-VEGF agents can lead to intraocular pressure control and symptomatic improvement in neovascular glaucoma.
- Anti-VEGF agents demonstrate dose-dependent inhibition of fibroblast proliferation, suggesting a role in wound modulation.
- Studies indicate potential benefits of anti-VEGF agents in enhancing bleb survival and function after trabeculectomy.
Conclusions:
- Anti-VEGF agents show significant promise for treating neovascular glaucoma and modulating wound healing post-trabeculectomy.
- The antiangiogenic and antifibroblastic properties of anti-VEGF agents may offer therapeutic advantages for various glaucoma conditions.
- Further prospective randomized clinical trials are necessary to solidify the role of anti-VEGF agents in glaucoma management.
Related Concept Videos
01:27Open Angle Glaucoma: Treatment
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
01:28Angle Closure Glaucoma: Treatment
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
01:25Glaucoma: Overview
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
01:27Diabetic Retinopathy
DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...